house fda generic drug labeling hearing
Published 8 years ago • 111 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
37:25
generic drug labeling: recommendations for high-quality submissions (4of28) generic drugs forum 2020
-
16:44
generic labeling: strategies for providing high-quality submissions (18/28) generic drugs forum 2017
-
2:12:15
examining concerns regarding fda's proposed changes to generic drug labeling
-
4:27
generic drug maker skipped steps required for fda approval
-
0:23
1. did you know 9 out of 10 prescriptions filled in the u.s. are for generic drugs? #fdafacts
-
0:46
house fda generic drug labeling hearing
-
16:19
referencing approved drug products in anda submissions (9of28) generic drugs forum – apr. 3-4, 2019
-
16:55
a dose of reality about generic drugs
-
2:37
generic drugs
-
7:53:33
electronic drug registration and listing (edrls) using cder direct – 2024
-
5:03
sarbanes discusses critical rules for generic drug labels with fda official
-
38:04
bottle of lies: how poor fda oversight & fraud in generic drug industry threaten patients’ health
-
50:52
navigating fda's drug information resources
-
14:51
why did the fda go easy on generic drug makers after inspections exposed quality & safety concerns?
-
1:24:05
fda’s labeling resources for human prescription drugs
-
55:25
common labeling deficiencies and tips for generic drug applications
-
3:14
us fda's generic labeling rule
-
11:47
good anda submission and assessment practices and software support (5of27) generic drugs forum 2018
-
18:47
challenges in generic drug safety and surveillance (6of27) generic drugs forum 2018
-
8:06:51
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access - day 1
-
1:43
generic drug makers could be required to label side effects
-
11:32
determining whether to submit an anda or a 505(b)(2) application (12of27) generic drugs forum 2018